IVIG is an option as a short-term, temporizing measure for patients with Rasmussen’s encephalitis.
Not recommended for long-term therapy.
Adults: Total dose of 2 g/kg divided over 2 to 5 days.
Pediatric: Total dose of 2 g/kg divided over 2 days.